Value in health regional issues
Cost-Effectiveness of Hydroxyurea for Treatment of Children With Sickle Cell Anemia in Ghana.
Sinaï Francisco Dias, Brian Asare, Lumbwe Chola
Published: 202610.1016/j.vhri.2025.101586
Abstract
OBJECTIVES: Most African children born with sickle cell disease (SCD) will die before their fifth birthday. Hydroxyurea has proven therapeutic benefits for SCD yet remains inaccessible to many children in low- and middle-income countries. To inform p…
Preview only. Read the full abstract at the source